High level of evidence from randomized controlled trials suggested that lycopene could be beneficial for cancer as seen in increment in apoptotic index among hyperplastic and neoplastic cells and suppression of PSA in prostate cancer patients [86,87,88]. The gene discussed is KLK3; the disease is Familial prostate cancer.